A close interaction between the virus SARS-CoV-2 and the immune system of an individual results in a diverse clinical manifestation of the COVID-19 disease. While adaptive immune responses are essential for SARS-CoV-2 virus clearance, the innate immune cells, such as macrophages, may contribute, in some cases, to the disease progression. Macrophages have shown a significant production of IL-6, suggesting they may contribute to the excessive inflammation in COVID-19 disease. Macrophage Activation Syndrome may further explain the high serum levels of CRP, which are normally lacking in viral infections. In adaptive immune responses, it has been revealed that cytotoxic CD8+ T cells exhibit functional exhaustion patterns, such as the expression of NKG2A, PD-1, and TIM-3. Since SARS-CoV-2 restrains antigen presentation by downregulating MHC class I and II molecules and, therefore, inhibits the T cell-mediated immune responses, humoral immune responses also play a substantial role. Specific IgA response appears to be stronger and more persistent than the IgM response. Moreover, IgM and IgG antibodies show similar dynamics in COVID-19 disease.

Laboratory of Cell Immunology Faculty of Science Charles University Prague Czech Republic; Department of Immunology 2nd Faculty of Medicine Charles University and University Hospital Motol Prague Czech Republic

Zobrazit více v PubMed

BARTON LM, DUVAL EJ, STROBERG E, GHOSH S, MUKHOPADHYAY S. COVID-19 autopsies, Oklahoma, USA. Am J Clin Pathol. 2020;153:725–733. doi: 10.1093/ajcp/aqaa062. PubMed DOI PMC

CAO X. COVID-19: immunopathology and its implications for therapy. Nat Rev Immunol. 2020;20:269–270. doi: 10.1038/s41577-020-0308-3. PubMed DOI PMC

CHAN JF, KOK KH, ZHU Z, CHU H, TO KK, YUAN S, YUEN KY. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect. 2020;9:221–236. doi: 10.1080/22221751.2020.1719902. PubMed DOI PMC

CHEN G, WU D, GUO W, CAO Y, HUANG D, WANG H, WANG T, ZHANG X, CHEN H, YU H, ZHANG X, ZHANG M, WU S, SONG J, CHEN T, HAN M, LI S, LUO X, ZHAO J, NING Q. Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest. 2020;130:2620–2629. doi: 10.1172/JCI137244. PubMed DOI PMC

CLEMENTZ MA, CHEN Z, BANACH BS, WANG Y, SUN L, RATIA K, BAEZ-SANTOS YM, WANG J, TAKAYAMA J, GHOSH AK, LI K, MESECAR AD, BAKER SC. Deubiquitinating and interferon antagonism activities of coronavirus papain-like proteases. J Virol. 2010;84:4619–4629. doi: 10.1128/JVI.02406-09. PubMed DOI PMC

DONG X, CAO YY, LU XX, ZHANG JJ, DU H, YAN YQ, AKDIS CA, GAO YD. Eleven faces of coronavirus disease 2019. Allergy. 2020. PubMed DOI PMC

FRIEMAN M, HEISE M, BARIC R. SARS coronavirus and innate immunity. Virus Res. 2008;133:101–112. doi: 10.1016/j.virusres.2007.03.015. PubMed DOI PMC

GAO M, YANG L, CHEN X, DENG Y, YANG S, XU H, CHEN Z, GAO X. A study on infectivity of asymptomatic SARS-CoV-2 carriers. Respir Med. 2020;169:106026. doi: 10.1016/j.rmed.2020.106026. PubMed DOI PMC

GRANT WB, LAHORE H, McDONNELL SL, BAGGERLY CA, FRENCH CB, ALIANO JL, BHATTOA HP. Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths. Nutrients. 2020;12:988. doi: 10.3390/nu12040988. PubMed DOI PMC

GRIFONI A, WEISKOPF D, RAMIREZ SI, MATEUS J, DAN JM, MODERBACHER CR, RAWLINGS SA, SUTHERLAND A, PREMKUMAR L, JADI RS, MARRAMA D, De SILVA AM, FRAZIER A, CARLIN A, GREENBAUM JA, PETERS B, KRAMMER F, SMITH DM, CROTTY S, SETTE A. Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals. Cell. 2020;181:1–13. doi: 10.1016/j.cell.2020.05.015. PubMed DOI PMC

GU J, GONG E, ZHANG B, ZHENG J, GAO Z, ZHONG Y, ZOU W, ZHAN J, WANG S, XIE Z, ZHUANG H, WU B, ZHONG H, SHAO H, FANG W, GAO D, PEI F, LI X, HE Z, XU D, SHI X, ANDERSON VM, LEONG AS. Multiple organ infection and the pathogenesis of SARS. J Exp Med. 2005;202:415–424. doi: 10.1084/jem.20050828. PubMed DOI PMC

GUO L, REN L, YANG S, XIAO M, CHANG D, YANG F, DELA CRUZ CS, WANG Y, WU C, XIAO Y, ZHANG L, HAN L, DANG S, XU Y, YANG Q, XU S, ZHU H, XU Y, JIN Q, SHARMA L, WANG L, WANG J. Profiling early humoral response to diagnose novel coronavirus disease (COVID-19) Clin Infect Dis. 2020. p. ciaa310. PubMed DOI PMC

HACKBART M, DENG X, BAKER SC. Coronavirus endoribonuclease targets viral polyuridine sequences to evade activating host sensors. Proc Natl Acad Sci U S A. 2020;117:8094–8103. doi: 10.1073/pnas.1921485117. PubMed DOI PMC

HOFFMANN M, KLEINE-WEBER H, SCHROEDER S, KRÜGER N, HERRLER T, ERICHSEN S, SCHIERGENS TS, HERRLER G, WU NH, NITSCHE A, MÜLLER MA, DROSTEN C, PÖHLMANN S. SARS-CoV-2 cell entry 384 depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease 385 inhibitor. Cell. 2020;181:271–280e8. doi: 10.1016/j.cell.2020.02.052. PubMed DOI PMC

HUANG C, WANG Y, LI X, REN L, ZHAO J, HU Y, ZHANG L, FAN G, XU J, GU X, CHENG Z, YU T, XIA J, WEI Y, WU W, XIE X, YIN W, LI H, LIU M, XIAO Y, GAO H, GUO L, XIE J, WANG G, JIANG R, GAO Z, JIN Q, WANG J, CAO B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506. doi: 10.1016/S0140-6736(20)30183-5. PubMed DOI PMC

JAILLON S, BERTHENET K, GARLANDA C. Sexual dimorphism in innate immunity. Clin Rev Allergy Immunol. 2019;56:308–321. doi: 10.1007/s12016-017-8648-x. PubMed DOI

JASON JR. Pathogenesis of COVID-19 from a cell biology perspective. Eur Respir J. 2020;55:2000607. doi: 10.1183/13993003.00607-2020. PubMed DOI PMC

LIU J, LI S, LIU J, LIANG B, WANG X, WANG H, LI W, TONG Q, YI J, ZHAO L, XIONG L, GUO C, TIAN J, LUO J, YAO J, PANG R, SHEN H, PENG C, LIU T, ZHANG Q, WU J, XU L, LU S, WANG B, WENG Z, HAN C, ZHU H, ZHOU R, ZHOU H, CHEN X, YE P, ZHU B, WANG L, ZHOU W, HE S, HE Y, JIE S, WEI P, ZHANG J, LU Y, WANG W, ZHANG L, LI L, ZHOU F, WANG J, DITTMER U, LU M, HU Y, YANG D, ZHENG X. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients. EBioMedicine. 2020;55:102763. doi: 10.1016/j.ebiom.2020.102763. PubMed DOI PMC

LIU W, FONTANET A, ZHANG PH, ZHAN L, XIN ZT, BARIL L, TANG F, LV H, CAO WC. Two-year prospective study of the humoral immune response of patients with severe acute respiratory syndrome. J Infect Dis. 2006;193:792–795. doi: 10.1086/500469. PubMed DOI PMC

McGONAGLE D, SHARIF K, O’REGAN A, BRIDGEWOOD C. The role of cytokines including interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease. Autoimmun Rev. 2020;19:102537. doi: 10.1016/j.autrev.2020.102537. PubMed DOI PMC

MOON C. Fighting COVID-19 exhausts T cells. Nat Rev Immunol. 2020;20:277. doi: 10.1038/s41577-020-0304-7. PubMed DOI PMC

OKBA NMA, MÜLLER MA, LI W, WANG C, GEURTSVANKESSEL CH, CORMAN VM, LAMERS MM, SIKKEMA RS, BRUIN E, CHANDLER FD, YAZDANPANAH Y, HINGRAT QL, DESCAMPS N, HOUHOU-FIDOUH N, REUSKEN CBEM, BOSCH BJ, DROSTEN C, KOOPMANS MPG, HAAGMANS BL. Severe acute respiratory syndrome coronavirus 2-specific antibody responses in coronavirus disease 2019 patients. Emerg Infect Dis. 26:2020. doi: 10.3201/eid2607.200841. PubMed DOI PMC

OKABAYASHI T, KARIWA H, YOKOTA S, IKI S, INDOH T, YOKOSAWA N, TAKASHIMA I, TSUTSUMI H, FUJII N. Cytokine regulation in SARS coronavirus infection compared to other respiratory virus infections. J Med Virol. 2006;78:417–424. doi: 10.1002/jmv.20556. PubMed DOI PMC

OPAL SM, GIRARD TD, ELY EW. The immunopathogenesis of sepsis in elderly patients. Clin Infect Dis. 2005;41(Suppl 7):S504–S512. doi: 10.1086/432007. PubMed DOI

PADOAN A, SCIACOVELLI L, BASSO D, NEGRINI D, ZUIN S, COSMA C, FAGGIAN D, MATRICARDI P, PLEBANI M. IgA-Ab response to spike glycoprotein of SARS-CoV-2 in patients with COVID-19: A longitudinal study. Clin Chim Acta. 2020;507:164–166. doi: 10.1016/j.cca.2020.04.026. PubMed DOI PMC

PARK MD. Macrophages: a Trojan horse in COVID-19? Nat Rev Immunol. 2020;20:351. doi: 10.1038/s41577-020-0317-2. PubMed DOI PMC

PROMPETCHARA E, KETLOY C, PALAGA T. Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic. Asian Pac J Allergy Immunol. 2020;38:1–9. doi: 10.12932/AP-200220-0772. PubMed DOI

RAJENDRAN K, KRISHNASAMY N, RANGARAJAN J, RATHINAM J, NATARAJAN M, RAMACHANDRAN A. Convalescent plasma transfusion for the treatment of COVID-19: Systematic review. J Med Virol. 2020. PubMed DOI PMC

RIZZO P, VIECELI DALLA SEGA F, FORTINI F, MARRACINO L, RAPEZZI C, FERRARI R. COVID-19 in the heart and the lungs: could we “Notch” the inflammatory storm? Basic Res Cardiol. 2020;115:31. doi: 10.1007/s00395-020-0791-5. PubMed DOI PMC

RUSSELL B, MOSS C, GEORGE G, SANTAOLALLA A, COPE A, PAPA S, Van HEMELRIJCK M. Associations between immune-suppressive and stimulating drugs and novel COVID-19-a systematic review of current evidence. Ecancermedicalscience. 2020;14:1022. doi: 10.3332/ecancer.2020.1022. PubMed DOI PMC

SHAKOORY B, CARCILLO JA, CHATHAM WW, AMDUR RL, ZHAO H, DINARELLO CA, CRON RQ, OPAL SM. Interleukin-1 receptor blockade is associated with reduced mortality in sepsis patients with features of macrophage activation syndrome: reanalysis of a prior phase III Trial. Crit Care Med. 2016;44:275–281. doi: 10.1097/CCM.0000000000001402. PubMed DOI PMC

SHI Y, WANG Y, SHAO C, HUANG J, GAN J, HUANG X, BUCCI E, PIACENTINI M, IPPOLITO G, MELINO G. COVID-19 infection: the perspectives on immune responses. Cell Death Differ. 2020;27:1451–1454. doi: 10.1038/s41418-020-0530-3. PubMed DOI PMC

SIU KL, KOK KH, NG MH, POON VK, YUEN KY, ZHENG BJ, JIN DY. Severe acute respiratory syndrome coronavirus M protein inhibits type I interferon production by impeding the formation of TRAF3.TANK.TBK1/IKKepsilon complex. J Biol Chem. 2009;284:16202–16209. doi: 10.1074/jbc.M109.008227. PubMed DOI PMC

SMITS SL, De LANG A, Van Den BRAND JM, LEIJTEN LM, Van IJCKEN WF, EIJKEMANS MJ, Van AMERONGEN G, KUIKEN T, ANDEWEG AC, OSTERHAUS AD, HAAGMANS BL. Exacerbated innate host response to SARS-CoV in aged non-human primates. PLoS Pathog. 2010;6:e1000756. doi: 10.1371/journal.ppat.1000756. PubMed DOI PMC

THEVARAJAN I, NGUYEN THO, KOUTSAKOS M, DRUCE J, CALY L, Van de SANDT CE, JIA X, NICHOLSON S, CATTON M, COWIE B, TONG SYC, LEWIN SR, KEDZIERSKA K. Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19. Nat Med. 2020;26:453–455. doi: 10.1038/s41591-020-0819-2. PubMed DOI PMC

TO KK, TSANG OT, LEUNG WS, TAM AR, WU TC, LUNG DC, YIP CC, CAI JP, CHAN JM, CHIK TS, LAU DP, CHOI CY, CHEN LL, CHAN WM, CHAN KH, IP JD, NG AC, POON RW, LUO CT, CHENG VC, CHAN JF, HUNG IF, CHEN Z, CHEN H, YUEN KY. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study. Lancet Infect Dis. 2020;20:565–574. doi: 10.1016/S1473-3099(20)30196-1. PubMed DOI PMC

TOTURA AL, WHITMORE A, AGNIHOTHRAM S, SCHÄFER A, KATZE MG, HEISE MT, BARIC RS. Toll-like receptor 3 signaling via TRIF Contributes to a protective innate immune response to severe acute respiratory syndrome coronavirus infection. mBio. 2015;6:e00638–15. doi: 10.1128/mBio.00638-15. PubMed DOI PMC

WANG C, LI W, DRABEK D, OKBA NMA, Van HAPEREN R, OSTERHAUS ADME, Van KUPPEVELD FJM, HAAGMANS BL, GROSVELD F, BOSCH BJ. A human monoclonal antibody blocking SARS-CoV-2 infection. Nat Commun. 2020;11:2251. doi: 10.1038/s41467-020-16256-y. PubMed DOI PMC

WANG Y, LIU L. The membrane protein of severe acute respiratory syndrome coronavirus functions as a novel cytosolic pathogen-associated molecular pattern to promote beta interferon induction via a toll-like-receptor-related TRAF3-independent mechanism. mBio. 2016;7:e01872–15. doi: 10.1128/mBio.01872-15. PubMed DOI PMC

WESTON S, FRIEMAN MB. COVID-19: Knowns, unknowns, and questions. mSphere. 2020;5:e00203–20. doi: 10.1128/mSphere.00203-20. PubMed DOI PMC

WU LP, WANG NC, CHANG YH, TIAN XY, NA DY, ZHANG LY, ZHENG L, LAN T, WANG LF, LIANG GD. Duration of antibody responses after severe acute respiratory syndrome. Emerg Infect Dis. 2007;13:1562–1564. doi: 10.3201/eid1310.070576. PubMed DOI PMC

XU Z, SHI L, WANG Y, ZHANG J, HUANG L, ZHANG C, LIU S, ZHAO P, LIU H, ZHU L, TAI Y, BAI C, GAO T, SONG J, XIA P, DONG J, ZHAO J, WANG FS. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8:420–422. doi: 10.1016/S2213-2600(20)30076-X. PubMed DOI PMC

YAO XH, LI TY, HE ZC, PING YF, LIU HW, YU SC, MOU HM, WANG LH, ZHANG HR, FU WJ, LUO T, LIU F, CHEN C, XIAO HL, GUO HT, LIN S, XIANG DF, SHI Y, LI QR, HUANG X, CUI Y, LI XZ, TANG W, PAN PF, HUANG XQ, DING YQ, BIAN XW. A pathological report of three COVID-19 cases by minimally invasive autopsies. (In Chinese) Zhonghua Bing Li Xue Za Zhi. 2020;49:411–417. doi: 10.3760/cma.j.cn112151-20200312-00193. PubMed DOI

YU N, LI W, KANG Q, XIONG Z, WANG S, LIN X, LIU Y, XIAO J, LIU H, DENG D, CHEN S, ZENG W, FENG L, WU J. Clinical features and obstetric and neonatal outcomes of pregnant patients with COVID-19 in Wuhan, China: a retrospective, single-centre, descriptive study. Lancet Infect Dis. 2020;20:559–564. doi: 10.1016/S1473-3099(20)30176-6. PubMed DOI PMC

YU X, YANG R. COVID-19 transmission through asymptomatic carriers is a challenge to containment. Influenza Other Respir Viruses. 2020. PubMed DOI PMC

ZENG G, XIE SY, LI Q. Infectivity of severe acute respiratory syndrome during its incubation period. Biomed Environ Sci. 2009;22:502–510. doi: 10.1016/S0895-3988(10)60008-6. PubMed DOI PMC

ZHANG W, ZHAO Y, ZHANG F, WANG Q, LI T, LIU Z, WANG J, QIN Y, ZHANG X, YAN X, ZENG X, ZHANG S. The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China. Clin Immunol. 2020;214:108393. doi: 10.1016/j.clim.2020.108393. PubMed DOI PMC

ZHAO J, YUAN Q, WANG H, LIU W, LIAO X, SU Y, WANG X, YUAN J, LI T, LI J, QIAN S, HONG C, WANG F, LIU Y, WANG Z, HE Q, LI Z, HE B, ZHANG T, FU Y, GE S, LIU L, ZHANG J, XIA N, ZHANG Z. Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019. Clin Infect Dis. 2020. p. ciaa344. PubMed DOI PMC

ZHENG M, GAO Y, WANG G, SONG G, LIU S, SUN D, XU Y, TIAN Z. Functional exhaustion of antiviral lymphocytes in COVID-19 patients. Cell Mol Immunol. 2020;17:533–535. doi: 10.1038/s41423-020-0402-2. PubMed DOI PMC

ZHOU F, YU T, DU R, FAN G, LIU Y, LIU Z, XIANG J, WANG Y, SONG B, GU X, GUAN L, WEI Y, LI H, WU X, XU J, TU S, ZHANG Y, CHEN H, CAO B. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054–1062. doi: 10.1016/S0140-6736(20)30566-3. PubMed DOI PMC

ZHOU P, YANG XL, WANG XG, HU B, ZHANG L, ZHANG W, SI HR, ZHU Y, LI B, HUANG CL, CHEN HD, CHEN J, LUO Y, GUO H, JIANG RD, LIU MQ, CHEN Y, SHEN XR, WANG X, ZHENG XS, ZHAO K, CHEN QJ, DENG F, LIU LL, YAN B, ZHAN FX, WANG YY, XIAO GF, SHI ZL. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270–273. https://doi.org/101038/s41586-020-2012-7 . PubMed PMC

ZHU N, ZHANG D, WANG W, LI X, YANG B, SONG J, ZHAO X, HUANG B, SHI W, LU R, NIU P, ZHAN F, MA X, WANG D, XU W, WU G, GAO GF, TAN W. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382:727–733. doi: 10.1056/NEJMoa2001017. PubMed DOI PMC

ZINKERNAGEL RM. On natural and artificial vaccinations. Annu Rev Immunol. 2003;21:515–546. doi: 10.1146/annurev.immunol.21.120601.141045. PubMed DOI

ZÜST R, CERVANTES-BARRAGAN L, HABJAN M, MAIER R, NEUMAN BW, ZIEBUHR J, SZRETTER KJ, BAKER SC, BARCHET W, DIAMOND MS, SIDDELL SG, LUDEWIG B, THIEL V. Ribose 2′-O-methylation provides a molecular signature for the distinction of self and non-self mRNA dependent on the RNA sensor Mda5, 2011. Nat Immunol. 2011;12:137–143. doi: 10.1038/ni.1979. PubMed DOI PMC

Muscle Dysfunction and Functional Status in COVID-19 Patients during Illness and after Hospital Discharge

ABCA3 and LZTFL1 Polymorphisms and Risk of COVID-19 in the Czech Population

Pyroptosis and airway homeostasis regulation

Vaccination Against SARS-CoV-2 in Lung Transplant Recipients: Immunogenicity, Efficacy and Safety

COVID-19 and Preexisting Comorbidities: Risks, Synergies, and Clinical Outcomes

Humoral and cellular immune responses to mRNA COVID-19 vaccines in patients with axial spondyloarthritis treated with adalimumab or secukinumab

Alveolar type II cells and pulmonary surfactant in COVID-19 era

SARS-CoV-2 viral load assessment in lung transplantation

Endocrine risk factors for COVID-19 in context of aging

Androgens in SARS-CoV-2 coronavirus infections

Effects of selected inherited factors on susceptibility to SARS-CoV-2 infection and COVID-19 progression

Interactions of renin-angiotensin system and COVID-19: the importance of daily rhythms in ACE2, ADAM17 and TMPRSS2 expression

Is there impact of the SARS-CoV-2 pandemic on steroidogenesis and fertility?

Could the CCR5-Delta32 mutation be protective in SARS-CoV-2 infection?

Inhibitory immune checkpoint molecules and exhaustion of T cells in COVID-19

Correlation between nongenomic action of C19-steroids and COVID-19 severity

CD4+ T Cells of Prostate Cancer Patients Have Decreased Immune Responses to Antigens Derived From SARS-CoV-2 Spike Glycoprotein

CCR5Delta32 deletion as a protective factor in Czech first-wave COVID-19 subjects

Principles and Challenges in anti-COVID-19 Vaccine Development

Interleukin-6: Molecule in the Intersection of Cancer, Ageing and COVID-19